Location History:
- Tarrytown, NY (US) (2018)
- Belmont, CA (US) (2023)
Company Filing History:
Years Active: 2018-2023
Title: Chad Michael May: Pioneering Innovations in Antibody Therapy
Introduction
Chad Michael May is an innovative inventor based in Tarrytown, NY, who has made significant contributions to the field of biotechnology. With a total of two patents to his name, May's work focuses on the development of advanced antibody therapies with crucial applications in cancer treatment.
Latest Patents
Chad Michael May’s latest innovations include two noteworthy patents. The first patent, titled "Anti-EDB antibodies and antibody-drug conjugates," revolves around antibodies and antibody-drug conjugates that specifically bind to the extra domain B splice variant of fibronectin 1. This invention delineates methods for preparing and utilizing these conjugates, showcasing May’s emphasis on therapeutic efficacy. The second patent, "Bispecific heterodimeric diabodies and uses thereof," describes bispecific heterodimeric diabody molecules aimed at treating cancer. These innovative molecules feature two polypeptide chains that create two epitope binding sites, specifically recognizing the P-cadherin tumor cell-associated antigen and the CD3 T cell antigen, potentially enhancing cancer treatment methodologies.
Career Highlights
Chad Michael May is currently employed at Pfizer Corporation, where he continues to advance his research and development in the field of antibody therapeutics. His work plays a pivotal role in the broader mission of Pfizer to develop innovative solutions to complex medical challenges.
Collaborations
Throughout his career, May has collaborated with other talented professionals, including Adam Reid Root and William Brady. These partnerships have allowed him to expand the potential applications of his inventions and enhance the research efforts at Pfizer Corporation.
Conclusion
Chad Michael May's contributions to antibody therapies are noteworthy, especially in the context of cancer treatment. With his recent patents and ongoing work at Pfizer Corporation, he stands out as a prominent figure in the field of biotechnology, driving innovation that shapes the future of healthcare.